Literature DB >> 4528109

Vitamin K dependent modifications of glutamic acid residues in prothrombin.

J Stenflo, P Fernlund, W Egan, P Roepstorff.   

Abstract

A tetrapeptide, residues 6 to 9 in normal prothrombin, was isolated from the NH(2)-terminal, Ca(2+)-binding part of normal prothrombin. The electrophoretic mobility of the peptide was too high to be explained entirely by its amino-acid composition. According to (1)H nuclear magnetic resonance spectroscopy and mass spectrometry, the peptide contained two residues of modified glutamic acid, gamma-carboxyglutamic acid (3-amino-1,1,3-propanetricarboxylic acid), a hitherto unidentified amino acid. This amino acid gives normal prothrombin the Ca(2+)-binding ability that is necessary for its activation. Observations indicate that abnormal prothrombin, induced by the vitamin K antagonist, dicoumarol, lacks these modified glutamic acid residues and that this is the reason why abnormal prothrombin does not bind Ca(2+) and is nonfunctioning in blood coagulation.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4528109      PMCID: PMC388542          DOI: 10.1073/pnas.71.7.2730

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Studies towards the complete sequence determination of proteins by mass spectrometry; a rapid procedure for the successful permethylation of histidine containing peptides.

Authors:  H R. Morris
Journal:  FEBS Lett       Date:  1972-05-15       Impact factor: 4.124

2.  Vitamin K and the biosynthesis of prothrombin. I. Identification and purification of a dicoumarol-induced abnormal prothrombin from bovine plasma.

Authors:  J Stenflo; P O Ganrot
Journal:  J Biol Chem       Date:  1972-12-25       Impact factor: 5.157

3.  Binding of Ca 2+ to normal and dicoumarol-induced prothrombin.

Authors:  J Stenflo; P O Ganrot
Journal:  Biochem Biophys Res Commun       Date:  1973-01-04       Impact factor: 3.575

4.  Dicumarol-induced prothrombin in bovine plasma.

Authors:  J Stenflo
Journal:  Acta Chem Scand       Date:  1970

5.  Plasma prothrombin during treatment with Dicumarol. II. Demonstration of an abnormal prothrombin fraction.

Authors:  P O Ganrot; J E Niléhn
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

6.  Plasma prothrombin during treatment with Dicumarol. I. Immunochemical determination of its concentration in plasma.

Authors:  J E Niléhn; P O Ganrot
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

7.  [Various molecular states of factor II (prothrombin). Their study by means of staphylocoagulase and anti-factor II antibodies. I. Factor II in patients treated with vitamin K antagonists].

Authors:  F Josso; J M Lavergne; M Gouault; O Prou-Wartelle; J P Soulier
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

8.  A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor).

Authors:  K Fujikawa; M H Coan; D L Enfield; K Titani; L H Ericsson; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

9.  The mode of action of vitamin K. Isolation of a peptide containing the vitamin K-dependent portion of prothrombin.

Authors:  G L Nelsestuen; J W Suttie
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  A polypeptide region of bovine prothrombin specific for binding to phospholipids.

Authors:  S N Gitel; W G Owen; C T Esmon; C M Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

View more
  104 in total

1.  Prothrombotic phenotype of protein Z deficiency.

Authors:  Z F Yin; Z F Huang; J Cui; R Fiehler; N Lasky; D Ginsburg; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Taking the thrombin "fork".

Authors:  Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07       Impact factor: 8.311

4.  Identification and purification to near homogeneity of the vitamin K-dependent carboxylase.

Authors:  S M Wu; D P Morris; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 5.  Some Important Milestones in the Field of Blood Clotting.

Authors:  Russell F Doolittle
Journal:  J Innate Immun       Date:  2015-12-15       Impact factor: 7.349

6.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

7.  Deamidation and disulfide bridge formation in human calbindin D28k with effects on calcium binding.

Authors:  Christophe Vanbelle; Frédéric Halgand; Tommy Cedervall; Eva Thulin; Karin S Akerfeldt; Olivier Laprévote; Sara Linse
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

8.  Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.

Authors:  Y Kawaguchi
Journal:  Jpn J Surg       Date:  1989-05

9.  Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene.

Authors:  Mamoru Igarashi; Yoshiko Yogiashi; Masatomo Mihara; Ichiro Takada; Hirochika Kitagawa; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

10.  No strict coupling of vitamin K1 (2-methyl-3-phytyl-1,4-naphthoquinone)-dependent carboxylation and vitamin K1 epoxidation in detergent-solubilized microsomal fractions from rat liver.

Authors:  R Wallin
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.